NCT00006196

Brief Summary

Vitamin D deficiency is common in the elderly and contributes to the increased incidence of falls, hip fracture and depression in this population. An unknown number of elderly have vitamin D resistance resulting in a functional vitamin D deficiency state. Because there are no simple procedures or blood tests that identify vitamin D resistance, its prevalence and contribution to disability in the elderly is unknown. Our inability to screen for this condition precludes our ability to initiate and monitor treatment. Previous studies indicate that fingernail thickness correlates with vitamin D status and may therefore provide a simple cost effective procedure to not only identify patients with vitamin D deficiency but also, those with vitamin D resistance. This procedure may also provide a way to monitor an individual's response to treatment. This study is designed to demonstrate the association between fingernail thickness and vitamin D status.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 8, 2000

Completed
Last Updated

June 24, 2005

Status Verified

December 1, 2003

First QC Date

September 7, 2000

Last Update Submit

June 23, 2005

Conditions

Keywords

Vitamin D resistance

Interventions

Eligibility Criteria

Age25 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • females 25-75 years of age with no known bone disorders

You may not qualify if:

  • history of vertebral fractures or nonvertebral fractures without trauma
  • prescription medications for prevention of osteoporosis (including vitamin D other than multivitamin and estrogen)
  • history of malignancy other than basal cell or squamous cell cancer of the skin
  • use of steroids or anticonvulsants in the 6 months prior to enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

4488 Forest Park, Suite 201

St Louis, Missouri, 63108, United States

Location

MeSH Terms

Conditions

Osteoporosis

Interventions

Vitamin D

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
DIAGNOSTIC
Sponsor Type
NIH

Study Record Dates

First Submitted

September 7, 2000

First Posted

September 8, 2000

Last Updated

June 24, 2005

Record last verified: 2003-12

Locations